5
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Plasma Omega-3 Fatty Acids Before and After Nutritional Therapy

Pages 25-34 | Published online: 13 Jul 2009

  • Burr GO, Burr MM. On the nature and role of fatty acids essential in nutrition. J Biol Chem 1930 86:587-9.
  • Burr GO, Burr MM. A new deficiency disease produced by rigid exclusion of fat from the diet. J Biol Chem 1929: 82: 345-67.
  • Karlsson J. Antioxidants and exercise. Champaign, IL: Human Kinetics Publishers, Inc. 1996.
  • FDA. Vitamin and mineral drug products for over-the-counter human use. Federal Register 1979; 44: 152-231.
  • Holman RT. Nutritional and metabolic relationships between fatty acids. Fed Proc 1964: 23: 1062-7.
  • Nelson AM. Diet therapy in coronary disease. Effect on mortality of high-protein, high sea-food. fat controlled diet. Geriatrics 1972); 7: 27-103.
  • Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos Am J Clin Nutr 1975; 28: 958-66.
  • Kromhout D, Bosschieter EB, deLezenne-Coulander C. The inverse relation betweenfish consumption and 20-years mortality from coronary disease. N Engl J Med 1985: 312: 1205-9.
  • Sanders TAB, Youngers KM. The effect of dietary supplements of n-3 polyunsaturated fatty acids on the tally acid composition of platelets and plasma choline phosphoglycerides. Br J Nutr 1981; 45: 13-16.
  • Dyerberg J. Linoleate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr Rev 1986: 44: 125-33.
  • Skjervold H. Lifestyle diseases--human diet. Meieriosten 1991:19: 527-9.
  • Leaf A. Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 3 18: 549-57.
  • Tinoco J. Dietary requirements of Alpha-linolenic acid in animal. Progr Lipid Res 1982: 21: 1-45.
  • Burton JL. Dietary fatty acids and inflammatory skin disease. Lancet 1989: 27-30.
  • Sprecher H. Biochemistry of essential tally acids. Progr Lipid Res 1981, 20: 13-22.
  • Kinsella JE, Lokesh B, Broughton S, et al. Dietary polyunsaturated fatty acids and eicosanoids, potential effect on the modulation of inflammatory and immune Cells: an overview. Nutrition 1990; 6:24-44.
  • Nielsen GL, Faarvang KL, Thompsen BS, et al. The effect of dietary Supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized double blind trial. Fur J Clin Invest 1992; 22: 687-91.
  • Charnock JS, McLennan PL, Sundram K, et al. Omega-3 PUFAs reduce the vulnerability of the rat heart to ischemic arrhythmia in the presence of a high intake of saturated animal fat. Nutr Res 1992; 12: 1491-502.
  • Ernster L, Forsmark P, Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes: relationship between the effects of ubiquinol and vitamin F. as inhibitors of lipid peroxidation in submitochondrial particles. BioFactors 1992; 3: 241-8.
  • Brenner RR. Oxidative desaturation of unsaturated fatty acids in animal. Mol Cell Biochem 1974; 3:47-52.
  • Hay CRM, Durber AP, Saynor R. Effect of fish oil on platelet kinetics in patients with ischemic heart disease. Lancet 1982; 1269-70.
  • NLN. Good Clinical Trial Practice. Nordic Guidelines. Norway: NLN Publications, 1993.
  • Sanders TAB. Studies of vegans: the fatty acid composition of plasma choline phosphoglycerides, erythrocytes, adipose tissue, and breast milk, and indicators of susceptibility to ischemic heart disease in vegans and omnivore controls. Am J Clin Nutt 1978; 31: 805-13.
  • Ackamn RG. Gas-liquid chromatography of fatty acids and esters. In: Loewenstaein JM, ed. Methods in Enzymology. New York: Academic Press, 1969; 329-46.
  • Karlsson J, Nygard B, Hesselius 6, et al. Plasma determination of ubiquinone, Alpha-tocopherol omega-3 and omega-6 fatty acids in healthy man and in some patient groups. Arkiv Kemi 1998.
  • Soyland E, Nenseter MS, Braathen LR, et al. Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T-lymphocytes in vitro. Fur J Clin Invest 1993; 23: 112-21.
  • Stone KJ, Willis AL, Hart M, et al. The metabolism of dihomo-gamma-linolenic acid in man. Lipids 1979; 14: 174-80.
  • GEIGY. Constituents of Living Matters-Vitamins. In: Lentner C, ed. Geigy Scientific Tables. Base]: CIBA-GEIGY Limited, 1986; 61-70.
  • Saltin B, Karlsson J. Die Ernahrung des Sportlers. In: Hollmann W, ed. Sportmedizin. Berlin: Springer-Verlag, 1986; 245-60.
  • Soyland E, Funk J, Rajka G, et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. N Engl J Med 1993; 328: 1845-6.
  • Karlsson J, Lin L, Sylven C, et al. Muscle ubiquinone in healthy physically active males. Mol Cell Biochem 1996; 156: 169-72.
  • Lindh G, Karlsson J, Ronneberg R. Plasma nutrients in joint and muscle pain patients before and after nutritional therapy. J Nutr Environ Med 1997; 7: 15-26.
  • Karlsson J, Stattin B. Ronneberg R. Plasma nutrients in elite cross-country skiers after nutratherapy. Int J Sports Nutr 1998.
  • Soyland E. The effect of very long-chain n-3 fatty acids on immunorelated skin diseases and some immune reactions. PhD Thesis, University of Oslo, 1993; 1-47.
  • Karlsson J, Diamant B, Theorell H, et al. Plasma alpha-tocopherol and ubiquinone and their relations to muscle function in healthy human and in cardiac diseases. In: Packer L, Fuchs J, eds. Vitamin E: Biochemistry and Clinical Applications. New York: Marcel Dekker, Inc, 1993; 473-93.
  • Halliwell B, Gutteridge JMC. Lipid peroxidation: a radical chain reaction. In: Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine. Oxford: Clarendon Press, 1989; 188-266.
  • Cornwell DG, Panganamala RV. Vitamin E action in modulating the arachidonic acid cascade. In: Packer L, Fuchs J, eds. Vitamin E: Biochemistry and Clinical Applications. New York: Marcel Dekker, Inc, 1993; 385-410.
  • Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 1991; 88: 1646-50.
  • Esterbauer H, Publ H, Waeg G, et al. The role of vitamin E in lipoprotein oxidation. In: Packer L, Fuchs J, eds. Vitamin E in Health and Disease. New York: Marcel Dekker Inc., 1993: 649-71.
  • Rocklin RE, Thistle L, Gallant L, et al. Altered arachidonic acid content in polymorphonuclear and mononuclear cells from patients with allergic rhinitis and/or asthma. Lipids 1986; 21: 17-20.
  • Warso MA, Lands WEM. Pathophysiological modulation of arachidonic acid metabolism. Clin Physiol Biochem 1984; 2: 70-7.
  • Goransson U, Karlsson J, Ronneberg R, et al. The Are sport nutratherapy program: The rational for food supplements in sports medicine. World Rev Nutr Diet 1997; 82: 101-21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.